Johnson & Johnson (JNJ) Leases (2019)
Johnson & Johnson recorded quarterly Leases of $957.0 million in Q4 2019, down 0.62% quarter-over-quarter from $963.0 million in Q3 2019.
Johnson & Johnson's Leases history runs 1 years deep, the most recent figure standing at $957.0 million for Q4 2019.
- In Q4 2019, Leases changed N/A year-over-year to $957.0 million; the TTM figure through Dec 2019 stood at $957.0 million (changed N/A YoY), while the FY2019 annual figure was $957.0 million, changed N/A from the prior year.
- Leases came in at $957.0 million for Q4 2019 at Johnson & Johnson, down from $963.0 million in the prior quarter.
- In the past five years, Leases ranged from a high of $980.0 million in Q2 2019 to a low of $879.0 million in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | - |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | - |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | - |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 1.53 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 29, 2019 | 957.00 Mn |
| Sep 29, 2019 | 963.00 Mn |
| Jun 30, 2019 | 980.00 Mn |
| Mar 31, 2019 | 879.00 Mn |